ProTx-III

CAT:
804-HY-P5153
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ProTx-III - image 1

ProTx-III

  • Description:

    ProTx-III is a selective and potent inhibitor of voltage-gated sodium channel Nav1.7, with an IC50 of 2.1 nM. ProTx-III is a spider venom peptide isolated from the venom of the Peruvian green velvet tarantella. ProTx-III has a typical inhibitor cystine knot motif (ICK) . ProTx-III is able to reverse the pain response. ProTx-III can be used to study diseases such as chronic pain, epilepsy, and arrhythmia[1].
  • Product Name Alternative:

    μ-TRTX-Tp1a
  • UNSPSC:

    12352209
  • Target:

    Sodium Channel
  • Type:

    Peptides
  • Related Pathways:

    Membrane Transporter/Ion Channel
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/protx-iii.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C([C@@H](N)CC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]2CSSC[C@H](NC3=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)[C@H](CC)C)=O)CC4=CNC=N4)=O)CC(C)C)=O)CCCCN)=O)=O)CCCCN)=O)CC(O)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)CCC1)=O)CC(N)=O)=O)CSSC[C@H](NC5=O)C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]3CC6=CNC7=CC=CC=C67)=O)CC(N)=O)=O)CC8=CNC=N8)=O)CC(N)=O)=O)CO)=O)=O)=O)CCCCN)=O)CC9=CNC%10=CC=CC=C9%10)=O)=O)CC%11=CC=CC=C%11)=O)CCCCN)=O)CC(C)C)=O)CSSC[C@H](NC2=O)C(N[C@H](C(NCC(N[C@H](C(N[C@H]5CCCCN)=O)CC(C)C)=O)=O)CO)=O
  • Molecular Formula:

    C162H246N52O43S6
  • Molecular Weight:

    3802.40
  • References & Citations:

    [1]Cardoso FC, et al. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens. Mol Pharmacol. 2015 Aug;88 (2) :291-303.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported
  • Isoform:

    Nav1.7
  • CAS Number:

    [1808297-63-3]